With over 35 nationalities and a range of backgrounds represented in our Benevolent team, we aim to build an inclusive environment where our people can bring their authentic selves to work, be respected for who they are and the exceptional work they do. We welcome and actively encourage applications from all sections of society and are committed to offering equal employment opportunities regardless of sex, race, religion or belief, ethnic or national origin, marital, domestic or civil partnership status, sexual orientation, gender identity, parental status, disability, age, citizenship, or any other basis. We see our diversity as an asset as we tackle challenging problems that bridge the gap between drug discovery and technology.
BenevolentAI is seeking an in-vivo drug discovery scientist to join our newly formed in-vivo project representative team where you will apply your experience as an in vivo pharmacologist and project representative to help drive our diverse portfolio to achieve key milestones. Reporting into the in-vivo project representative team leader and as a core member of a dynamic, multi-disciplinary team of scientists passionate about developing medicines, you will be the responsible in-vivo pharmacology project representative on multiple projects. Working collaboratively with project drug discovery project teams, including DMPK, chemistry, in-vivo and in-vitro colleagues, using your theoretical and practical expertise, you’ll take a hands-on approach to scoping, designing, implementing and interpreting in-vivo pharmacodynamic studies across the portfolio. You will supplement the analysis of results through histology, molecular and biochemical profiling. You will identify and build strong relationships with the best CROs to deliver the appropriate support for projects, build systems and deliver datasets that will have direct impact on project progression
BenevolentAI (AMS: BAI) is a leading, clinical-stage AI-enabled drug discovery and development company listed on the Euronext Amsterdam stock exchange. Through the combined capabilities of its AI platform, scientific expertise, and wet-lab facilities, BenevolentAI is well-positioned to deliver novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform™ powers a growing in-house pipeline of 13 named drug programmes and over 10 exploratory programmes, and it maintains successful collaborations with AstraZeneca, as well as leading research and charitable institutions. BenevolentAI is headquartered in London, with a research facility in Cambridge (UK) and a further office in New York.
We share a passion for being part of a mission that matters, and we are always looking for curious and collaborative people who share our values and want to be part of our journey. If that sounds like a fit for you, hit the ‘apply’ button and join us.
Head over to our Glassdoor page to learn about our benefits, culture and to find out what our team think about life at Benevolent. You can also find out more about us on LinkedIn and Twitter.
Enter your email address below to get notified whenever we find a similar job post.
Unsubscribe at any time.